DermTech (DMTK) Short Interest Ratio & Short Volume → Biggest hedge fund manager has huge warning for U.S. dollar (From Stansberry Research) (Ad) Free DMTK Stock Alerts $0.62 0.00 (0.00%) (As of 05/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media DermTech Short Interest DataCurrent Short Volume3,090,000 sharesPrevious Short Volume3,080,000 sharesChange Vs. Previous Month+0.32%Dollar Volume Sold Short$1.92 millionShort Interest Ratio / Days to Cover10.9Last Record DateApril 30, 2024Outstanding Shares34,623,000 sharesFloat Size30,500,000 sharesShort Percent of Float10.13%Today's Trading Volume139,657 sharesAverage Trading Volume292,574 sharesToday's Volume Vs. Average48% Short Selling DermTech ? Sign up to receive the latest short interest report for DermTech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatDMTK Short Interest Over TimeDMTK Days to Cover Over TimeDMTK Percentage of Float Shorted Over Time Ad Stansberry ResearchDo This Today BEFORE Biden Wins in NovemberDiscover "U.S.'s New Money" Before Biden Wins A new form of money has emerged in America, and it's making some folks wildly rich… (Musk and Bezos both use it).Find out how you can too in this free video. DermTech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20243,090,000 shares $1.92 million +0.3%10.1%10.9 $0.62 4/15/20243,080,000 shares $1.91 million -2.5%10.1%10.5 $0.62 3/31/20243,160,000 shares $2.22 million +0.6%10.3%9.4 $0.70 3/15/20243,140,000 shares $2.17 million -0.3%10.3%7.7 $0.69 2/29/20243,150,000 shares $4.03 million -5.1%10.3%6.2 $1.28 2/15/20243,320,000 shares $4.45 million +0.3%11.0%8 $1.34 Get the Latest News and Ratings for DMTK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for DermTech and its competitors with MarketBeat's FREE daily newsletter. 1/31/20243,310,000 shares $3.97 million +4.1%10.9%7.8 $1.20 1/15/20243,180,000 shares $4.52 million +4.3%10.5%7.3 $1.42 12/31/20233,050,000 shares $5.34 million +2.0%10.1%7 $1.75 12/15/20232,990,000 shares $4.63 million -47.6%9.9%7.4 $1.55 11/30/20235,710,000 shares $9.19 million +6.3%18.9%17.1 $1.61 11/15/20235,370,000 shares $8.32 million +4.1%17.8%22 $1.55 10/31/20235,160,000 shares $7.02 million -1.3%17.1%21.1 $1.36 10/15/20235,230,000 shares $6.38 million +7.2%17.6%21 $1.22 9/30/20234,880,000 shares $7.03 million +3.4%16.4%18.8 $1.44 9/15/20234,720,000 shares $8.54 million -2.1%15.8%17.1 $1.81 8/31/20234,820,000 shares $11.09 million +10.1%16.3%14.9 $2.30 8/15/20234,380,000 shares $10.47 million +7.6%14.9%13.1 $2.39 7/31/20234,070,000 shares $13.19 million +4.9%13.8%10.9 $3.24 7/15/20233,880,000 shares $12.26 million +6.6%14.3%9.1 $3.16 6/30/20233,640,000 shares $9.46 million +12.7%13.4%8.7 $2.60 6/15/20233,230,000 shares $9.37 million +14.5%11.9%8.1 $2.90 5/31/20232,820,000 shares $6.71 million -3.1%9.8%7.6 $2.38 5/15/20232,910,000 shares $6.87 million No Change10.1%7 $2.36 10/31/20222,770,000 shares $8.92 million -2.5%10.5%5.2 $3.22 10/15/20222,840,000 shares $9.57 million -3.4%10.8%5.4 $3.37 9/30/20222,940,000 shares $11.64 million +1.7%11.2%5 $3.96 9/15/20222,890,000 shares $16.01 million +2.9%11.0%4.5 $5.54 8/31/20222,810,000 shares $15.62 million -0.7%10.7%3.5 $5.56 8/15/20222,830,000 shares $20.26 million -29.3%10.8%3.2 $7.16 7/31/20224,000,000 shares $32.80 million +29.0%15.3%4.3 $8.20 7/15/20223,100,000 shares $19.56 million -8.0%11.9%3.2 $6.31 6/30/20223,370,000 shares $18.67 million -36.2%12.9%3.7 $5.54 6/15/20225,280,000 shares $25.03 million +2.3%20.1%5.7 $4.74 5/31/20225,160,000 shares $34.26 million -1.2%19.7%6.6 $6.64 5/15/20225,220,000 shares $40.92 million -19.8%19.8%7 $7.84 4/30/20226,510,000 shares $55.66 million +11.3%24.7%9.6 $8.55 4/15/20225,850,000 shares $69.91 million +5.2%22.3%9 $11.95 3/31/20225,560,000 shares $81.62 million -0.9%N/A8.1 $14.68 3/15/20225,610,000 shares $65.86 million -2.3%21.0%7.9 $11.74Biggest hedge fund manager has huge warning for U.S. dollar (Ad)Prescient CEO Makes Shocking New Prediction Known for his eerily accurate market calls over the years, this CEO has just revealed his newest prediction about "America's New Money."Get the details before it's taken offline. DMTK Short Interest - Frequently Asked Questions What is DermTech's current short interest? Short interest is the volume of DermTech shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 3,090,000 shares of DMTK short. 10.13% of DermTech's shares are currently sold short. Learn More on DermTech's current short interest. What is a good short interest ratio for DermTech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DMTK shares currently have a short interest ratio of 11.0. Learn More on DermTech's short interest ratio. Which institutional investors are shorting DermTech? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of DermTech: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for DermTech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.13% of DermTech's floating shares are currently sold short. Is DermTech's short interest increasing or decreasing? DermTech saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 3,090,000 shares, an increase of 0.3% from the previous total of 3,080,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is DermTech's float size? DermTech currently has issued a total of 34,623,000 shares. Some of DermTech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. DermTech currently has a public float of 30,500,000 shares. How does DermTech's short interest compare to its competitors? 10.13% of DermTech's shares are currently sold short. Here is how the short interest of companies compare to DermTech: Exagen Inc. (0.05%), Psychemedics Co. (0.35%), BioNexus Gene Lab Corp. (2.51%), OpGen, Inc. (1.59%), Renalytix Plc (0.81%), Enzo Biochem, Inc. (1.90%), Personalis, Inc. (3.03%), Streamline Health Solutions, Inc. (0.09%), Cue Health Inc. (0.46%), RenovoRx, Inc. (0.19%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short DermTech stock? Short selling DMTK is an investing strategy that aims to generate trading profit from DermTech as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against DermTech? A short squeeze for DermTech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DMTK, which in turn drives the price of the stock up even further. How often is DermTech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DMTK, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: XGN Short Squeeze PMD Short Squeeze BGLC Short Squeeze OPGN Short Squeeze RNLX Short Squeeze ENZ Short Squeeze PSNL Short Squeeze STRM Short Squeeze HLTH Short Squeeze RNXT Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DMTK) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin AnalyticsBiden Nomination CANCELED?The Freeport Society